TA
KNSA icon

Teachers Advisors’s Kiniksa Pharmaceuticals KNSA Stock Holding History

Teachers Advisors’s Portfolio KNSA Stock Details KNSA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q1 		$299K Buy
16,565
+8,107
+96% +$157K ﹤0.01% 2730
2018
Q4 		$238K Hold
8,458
– – ﹤0.01% 2795
2018
Q3 		$216K Buy
+8,458
New +$164K ﹤0.01% 2921

Other funds holding KNSA

BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
HA
HHLR Advisors Grand Cayman, Cayman Islands $832M AUM 32.38% 1-Year Est. Return
ACH
ArrowMark Colorado Holdings Denver, Colorado $2.4B AUM 42.85% 1-Year Est. Return
DM
Deerfield Management New York $9.59B AUM 113.36% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
SI
Sofinnova Investments Menlo Park, California $1.93B AUM 134.74% 1-Year Est. Return
VC
Vivo Capital Palo Alto, California $1.1B AUM 799.93% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
VMI
VHCP Management II New York $379M AUM 421.62% 1-Year Est. Return

Teachers Advisors's KNSA Position: Q1 2019 in Review

Teachers Advisors increased its Kiniksa Pharmaceuticals (KNSA) stake by 96% in Q1 2019, buying an estimated $157K and bringing the position to 16,565 shares worth $299K. The position accounts for ﹤0.01% of the portfolio, ranked #2730.

Teachers Advisors first reported a position in KNSA in Q3 2018 and has held it in 3 quarters since. 56 funds tracked by Wall St. Rank hold KNSA as of Q1 2019.

  • Teachers Advisors held 16,565 shares of Kiniksa Pharmaceuticals worth $299K as of Q1 2019.
  • Teachers Advisors bought 8,107 Kiniksa Pharmaceuticals shares in Q1 2019, an estimated $157K.
  • Kiniksa Pharmaceuticals made up ﹤0.01% of Teachers Advisors's portfolio in Q1 2019, its #2730 holding.
  • Teachers Advisors first reported a position in Kiniksa Pharmaceuticals in Q3 2018 and has held it in 3 quarters since.
  • 56 funds tracked by Wall St. Rank held Kiniksa Pharmaceuticals as of Q1 2019.

Based on Teachers Advisors's 13F filing for Q1 2019, filed 14 May 2019.